Test of a new camera for iodine 131 thyroid cancer imaging
Part of Cancer, Hormones & metabolism clinical trials.
This study compares two types of scanning cameras to see how well they record images in people with thyroid cancer treated with iodine 131. It may help improve which camera gives clearer results after this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older) and willing to sign informed consent
- You have thyroid cancer and your care team has approved treatment with iodine 131
- You should be able to safely have the scan and have no reason you can’t do it
- You must not be allergic to iodine 131 (or the capsule ingredients)
- You must be able to lie still on your back during the scan
- You must have health coverage through the social security system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well a new PET/CT scan (18F-TFB) can find thyroid cancer after a standard iodine whole-body scan. It may help doctors see where the cancer is using an added imaging test, which could improve planning for care.
This study tests whether a specialized nuclear imaging camera can better detect multiple tumors or lesions in your body. You'll receive a standard radioactive tracer scan (like a bone scan or thyroid scan) that's already part of your care, but we'll also image you with this newer camera technology to see if it works well.
This trial tests a special camera (VERITON-CT) to help guide precise radiation for bone tumors that have spread from prostate cancer. It may improve targeting accuracy during treatment.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
This trial tests whether a new type of scan (I-124 PET/CT) can better detect thyroid cancer compared to standard scans. It may help doctors decide on the best treatment, such as radiation therapy or surgery.
This early-stage study tests how well a special iodine scan (using iodine-124) can help plan treatment with radioactive iodine (iodine-131) for thyroid cancer that has spread. It may help doctors decide the right way to measure and target radioiodine-avid (radioiodine-absorbing) metastases.
Hear when a new Device trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.